China Just Froze a $35 Billion U.S. Merger -- And Investors Should Pay Attention
The $35 billion merger between Synopsys (SNPS) and Ansys has hit a significant roadblock as China's antitrust regulator postponed its final approval following renewed U.S. export controls. The proposed tie-up, which had already advanced to the final review stage by China's State Administration for Market Regulation, now faces uncertainty after the Trump administration expanded restrictions on semiconductor design software and other sensitive technologies to China. According to sources cited by the Financial Times, the delay is directly tied to Washington's latest move in late May to restrict sales of chip design toolsaffecting companies like Synopsyswithout special licenses.
Warning! GuruFocus has detected 3 Warning Sign with GME.
The timing of the setback comes just days after U.S. and Chinese officials reached a tentative truce in London to ease broader trade friction. However, the agreement appears fragile, with Beijing's curbs on critical mineral exports triggering further U.S. clampdowns. As a result, licenses for certain suppliers have been revoked, and a broader licensing regime has been reinstated. For Synopsys and Ansys, these geopolitical shifts now threaten to derail a merger that had already cleared regulatory hurdles in all other jurisdictions except China. Neither company, nor the Chinese regulator, has publicly commented on the reported delay.
On the domestic front, the U.S. Federal Trade Commission last month required the divestiture of certain assets to alleviate antitrust concerns tied to the deal. Synopsys CEO has indicated that regulatory approval has been secured globallywith China as the sole outlier. Investors are watching closely as the delay could stretch the closing timeline or possibly trigger renegotiation risks, especially if trade tensions escalate further.
This article first appeared on GuruFocus.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Should You Investigate QES Group Berhad (KLSE:QES) At RM0.36?
QES Group Berhad (KLSE:QES), is not the largest company out there, but it saw significant share price movement during recent months on the KLSE, rising to highs of RM0.48 and falling to the lows of RM0.34. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether QES Group Berhad's current trading price of RM0.36 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let's take a look at QES Group Berhad's outlook and value based on the most recent financial data to see if there are any catalysts for a price change. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. According to our price multiple model, which makes a comparison between the company's price-to-earnings ratio and the industry average, the stock price seems to be justfied. We've used the price-to-earnings ratio in this instance because there's not enough visibility to forecast its cash flows. The stock's ratio of 19.08x is currently trading slightly above its industry peers' ratio of 18.46x, which means if you buy QES Group Berhad today, you'd be paying a relatively sensible price for it. And if you believe that QES Group Berhad should be trading at this level in the long run, then there should only be a fairly immaterial downside vs other industry peers. So, is there another chance to buy low in the future? Given that QES Group Berhad's share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us an opportunity to buy later on. This is based on its high beta, which is a good indicator for share price volatility. Check out our latest analysis for QES Group Berhad Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Though in the case of QES Group Berhad, it is expected to deliver a relatively unexciting earnings growth of 5.1%, which doesn't help build up its investment thesis. Growth doesn't appear to be a main reason for a buy decision for QES Group Berhad, at least in the near term. Are you a shareholder? It seems like the market has already priced in QES's growth outlook, with shares trading around industry price multiples. However, there are also other important factors which we haven't considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at QES? Will you have enough conviction to buy should the price fluctuate below the industry PE ratio? Are you a potential investor? If you've been keeping tabs on QES, now may not be the most optimal time to buy, given it is trading around industry price multiples. However, the positive growth outlook may mean it's worth diving deeper into other factors in order to take advantage of the next price drop. Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. For example, we've discovered 2 warning signs that you should run your eye over to get a better picture of QES Group Berhad. If you are no longer interested in QES Group Berhad, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Black America Web
an hour ago
- Black America Web
Social Security Projected To 'Go-Broke' Earlier Than Expected
Source: filo / Getty I'm 32, and for as long as I can remember, I've heard about how Social Security was on its way to being depleted. It's been a known issue, yet there's been no meaningful legislation to address it. As a result, rising health costs and recent legislation have led to the projected 'go-broke' date moving up for both Social Security and Medicare. According to AP, an annual report released on Wednesday projects the go-broke date for the Social Security trust will occur in 2034, a year up from last year's projection of 2035. For Medicare, the new date was a bit more drastic, going up from 2036 to 2033. Now, to be clear, the go-broke date doesn't mean benefits will be stopped outright. It simply means payouts will be given at a reduced rate. For Social Security, it's estimated that benefit payouts would be capped at 81 percent, and for Medicare, the government provided health insurance that covers people age 65 and older, it's estimated that payments would only cover 89 percent of costs for patients' hospital visits, hospice care, and nursing home stays. This reduction would significantly affect the 68 million Americans currently enrolled in Medicare, The Social Security and Medicare trust funds are overseen by four trustees. The Treasury Secretary serves as managing trustee, with the Secretaries of Labor, Health and Human Services, and the Commissioner of Social Security being the other three. The trustee board technically has two other presidentially-appointed and Senate-confirmed trustees who serve as public representatives, but those roles have been empty for over a decade. 'Current-law projections indicate that Medicare still faces a substantial financial shortfall that needs to be addressed with further legislation. Such legislation should be enacted sooner rather than later to minimize the impact on beneficiaries, providers, and taxpayers,' the trustees state in the report. The go-broke date for Social Security has fluctuated quite a bit in recent years, with annual reports from recent years projecting 'go-broke' dates in 2026, 2028, and 2031, respectively. A poll conducted by AP last month revealed that 3 in 10 Americans over 60 are not confident that Social Security benefits would be there for them if they needed them. Clearly, this news won't do much to increase their confidence. Social Security Administration Commissioner Frank Bisignano, who was only sworn into his role last month, released a statement saying that 'the financial status of the trust funds remains a top priority for the Trump Administration.' This seems like another instance of the Trump administration being all talk, little action, as there seems to be very little meaningful legislation to address the issue. In fact, Trump's 'Big, Beautiful' budget bill has very little in the way of relief for Social Security and Medicare. As a millennial with very little faith in America's ability to improve upon itself, I would very much like it if I could opt out of paying Social Security because while I'm not over 60, I have very little faith that the benefits are going to be there for me by the time I can use them. Heck, at the rate we're going, I'd honestly just be happy if we even have a functional democracy at that point. SEE ALSO: Trump's 'Big, Beautiful Bill' Will Destroy Medicare, Food Stamps Student Loan Collections Make American Credit Scores Plummet SEE ALSO Social Security Projected To 'Go-Broke' Earlier Than Expected was originally published on Black America Web Featured Video CLOSE
Yahoo
2 hours ago
- Yahoo
It sounds sick, but Iran hostilities may be good for stocks
It sounds sick, but Iran hostilities may be good for stocks originally appeared on TheStreet. So, President Trump ordered B-2 bombers to drop bunker-busting bombs on three Iranian nuclear facilities late Saturday. He pronounced the result "a spectacular success," with Iran's nuclear enrichment facilities "completely and totally obliterated." There will be lots of media coverage Sunday and beyond on whether the operation worked and whether the United States will be dragged into a third war in the Middle East since 1991. 💵💰💰💵 A question for investors, however, is this: How will stocks react?There are some unknowns. There's been no verification that Iran's nuclear enrichment facilities are, in fact, totally obliterated. It's not clear if Iran will try to cut a deal to stop the Israeli and U.S. bombing or opt somehow to play a long game of defending itself with missile shots at Israel and U.S. military bases in the Middle East. Nonetheless, there's a good chance Wall Street will seize on the attacks as a prime stock-buying opportunity. That's what happened in 2003's Second Gulf War when U.S.-led forces invaded Iraq and toppled the dictatorial regime of Saddam started to tumble in late January 2003 as another war against Iraq became inevitable. The Standard & Poor's 500 Index was down as much as 9% for the year on March 11. But then investors started to believe the invasion would go well, and the S&P 500 started to recover. Indeed, when Baghdad fell on April 9, 2003, the index had recovered all the early losses and was up 8.2% from the March low. And stocks never looked back. The S&P 500 finished up 26.4% in 2023. The gain from the March 2003 low to year-end: 38%. One will be able to see how investors and markets are looking at the conflict starting at 6 p.m. ET Sunday. That's when futures trading in the S&P 500, the Dow Jones industrials and the Nasdaq-100 starts. Gains like 2003 might not happen. Iran was lobbing missiles at the Israeli cities of Tel Aviv and Haifa into Sunday. And, so far, there's no hint that Iran's leadership wants a cease fire. A prolonged fight might be bad for stocks. Iran has missiles and drones to deploy. It could block off Strait of Hormuz, through which 25% of the world's crude oil is shipped. Blocking the strait would send global oil prices sharply higher and cause havoc for the global economy. in fact, oil prices already have reacted. As tensions have grown between Israel and Iran (and now the United States), crude oil has climbed 29.3% to $73.84 per 42-gallon barrel from a May 5 closing low. U.S. gasoline prices have risen, too, about 4% or so, to about $3.20 a gallon, according to companies would profit. In fact, stocks in the S&P 500's Energy Sector are up 9.2% so far in June, the best performance by any of the 11 S&P 500 sectors. Oil-and-gas producer APA Corp. () , the sector leader is up 15.8% over the last month, according to data. Exxon Mobil () has jumped 9.3%; Chevron () is has risen almost 9%. More Experts Analyst makes bold call on stocks, bonds, and gold TheStreet Stocks & Markets Podcast #8: Common Sense Investing With David Miller Veteran fund manager sends dire message on stocks Theoretically, the first-quarter earnings seasons is done, but some of the late stragglers due this week are important. These include: FedEx () , after Tuesday's close. FedEx shares have struggled, but there is hope. The delivery giant is doing business again with () , and its business overall is growing again. But shares are off nearly 20% this year because of tariff worries. Earnings are estimated to rise 8.9% from a year ago to $5.89 a share. Revenue will be off slightly at $21.8 billion. Cruise-line giant Carnival Corp. () , before Tuesday's open. Between August 2024 and Jan. 30, the shares doubled to $28.49 because bookings were beyond terrific. Then, the shares fell 49%, thanks to the Trump tariff plan and the mini-stock panic. Carnival is back to $23.77. The quarterly revenue estimate of $6.2 billion is up 7.3% from a year ago. Earnings of 24 cents a share would be up 118%. Chip maker Micron Technology () shares are up 47% this year, and Wall Street likes — no, loves — the stock, whose chips have carved out a lucrative spot in artificial intelligence. In fact, the shares are already ahead of one analyst's one-year price target. The revenue estimate is $8.8 billion, up nearly 30% from a year ago. Earnings of $1.59 a share would be up 156%. Nike () is having a challenging year. The shares are down 21% this year, third-worst among the Dow Jones industrial stocks. True, it's selling athletic wear and shoes again on but it is extremely vulnerable to the Trump tariff hikes. Barrons says Nike's factories in Vietnam, Indonesia and China manufacture 50%, 27% and 18% of all its footwear. (Yes, that adds up to 95% of production.) The Nike revenue estimate: $10.7 billion, down 15.1% from a year ago. Earnings of 12 cents would be down 88%.It sounds sick, but Iran hostilities may be good for stocks first appeared on TheStreet on Jun 22, 2025 This story was originally reported by TheStreet on Jun 22, 2025, where it first appeared. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
